Oncology (all articles)

“The results suggest that (1) CEA testing should not be used alone as a triage test; (2) in year 1, testing frequency should be increased (to monthly for 3 months and then every 2 months); (3) the threshold for investigating a single test result should be raised to 10 µg/l; (4) after the second CEA test, decisions to investigate further should be made on the basis of the trend in CEA levels; (5) the optimal threshold for investigating the CEA trend falls over time; and (6) continuing smokers should not be monitored with CEA testing”.

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome

23 Jul, 2017 | 13:33h | UTC

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) – Journal of Clinical Oncology (free)

Commentaries: Reduced-Intensity vs Standard Conditioning Followed by ASCT in Myelodysplastic Syndrome – ASCO Post (free) AND Results of prospective randomized phase III study of the EBMT (Ricmac trial) dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation for patients with myelodysplastic syndrome – European Society for Blood and Marrow Transplantation, via EurekAlert (free)

Source: EvidenceAlerts (free resource to find articles of interest)

Guideline: Molecular Biomarkers for the Evaluation of Colorectal Cancer

22 Jul, 2017 | 20:10h | UTC

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology (free)

Commentaries: ASCP/CAP/AMP/ASCO Guideline on Molecular Biomarkers in Colorectal Cancer – ASCO Post (free) AND ASCP/CAP/AMP/ASCO Clinical Practice Guideline Focuses on Molecular Biomarker Testing for Patients With Colorectal Cancer – ASCO Post (free) AND Clinical Practice Guideline Focuses on Molecular Biomarker Testing for Patients with Colorectal Cancer – College of American Pathologists (CAP), via NewsWise (free)

Source: Oncology Research Review Newsletter (free registration required)

Commentaries: ASCO Offers Path to Addressing Affordability of Cancer Drugs in New Position Statement – ASCO Post (free) AND ASCO Tackles Affordability of Cancer Drugs – Physician’s First Watch (free) AND ASCO Advocates Value in Drug Pricing – MedPage Today (free registration required) AND ASCO Addresses High Cost of Cancer Drugs – Medscape (free registration required)

New European Society of Medical Oncology (ESMO) Updated Clinical Practice Guidelines

20 Jul, 2017 | 00:07h | UTC

Homepage – New European Society of Medical Oncology (ESMO) Updated Clinical Practice Guidelines

New available guidelines are:

– Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

– Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

– Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

– Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

– Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

– Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

– EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours (free)

– Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines (free)

– Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (free)

Practice guidelines for management of uterine corpus cancer

18 Jul, 2017 | 23:14h | UTC

Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement (free)

Guideline: Colorectal neuroendocrine neoplasms

18 Jul, 2017 | 23:12h | UTC

Colorectal neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours) (free PDF)

Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma

18 Jul, 2017 | 23:13h | UTC

Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO) (free)

Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease

Advances in surgical management for locally recurrent rectal cancer

Endoscopic ultrasound in oncology: An update of clinical applications in the gastrointestinal tract

Update in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas

Advances in the Diagnosis and Management of Colonic Dysplasia in Patients With Inflammatory Bowel Disease

Recent Advances in the Neoadjuvant Treatment of Breast Cancer

Parkinson Disease and Melanoma

Why cancer is not a war, fight, or battle

Management of malignant pleural effusion: challenges and solutions

Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up?

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome

Guideline: Molecular Biomarkers for the Evaluation of Colorectal Cancer

HPV vaccines – A review of the first decade

Novel immunotherapy in metastatic renal cell carcinoma

American Society of Clinical Oncology Position Statement On Addressing the Affordability of Cancer Drugs

New European Society of Medical Oncology (ESMO) Updated Clinical Practice Guidelines

Practice guidelines for management of uterine corpus cancer

Guideline: Colorectal neuroendocrine neoplasms

Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma

Guideline: Gastroduodenal neuroendocrine neoplasms, including gastrinoma

Guideline: Pancreatic neuroendocrine neoplasms

Guideline: Neuroendocrine neoplasms of the small intestine and appendix

Bone targeted therapies in advanced breast cancer

Stay Updated in Your Specialty